{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T01:16:13Z","timestamp":1788830173299,"version":"build-2803163510"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,2,12]],"date-time":"2025-02-12T00:00:00Z","timestamp":1739318400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2025,2,12]],"date-time":"2025-02-12T00:00:00Z","timestamp":1739318400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"Universit\u00e0 degli Studi di Roma La Sapienza"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Pharmacokinet"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1007\/s40262-025-01474-8","type":"journal-article","created":{"date-parts":[[2025,2,12]],"date-time":"2025-02-12T10:43:38Z","timestamp":1739357018000},"page":"453-462","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Plasma Concentrations of Direct Oral Anticoagulants in Patients with Nonvalvular Atrial Fibrillation and Different Degrees of Obesity"],"prefix":"10.1007","volume":"64","author":[{"given":"Danilo","family":"Menichelli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arianna","family":"Pannunzio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erminia","family":"Baldacci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vittoria","family":"Cammisotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Castellani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosaria","family":"Mormile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilaria Maria","family":"Palumbo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Chistolini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Violi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Job","family":"Harenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6357-5213","authenticated-orcid":false,"given":"Daniele","family":"Pastori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pasquale","family":"Pignatelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,12]]},"reference":[{"key":"1474_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.compbiomed.2021.104754","volume":"136","author":"M Safaei","year":"2021","unstructured":"Safaei M, Sundararajan EA, Driss M, Boulila W, Shapi\u2019i A. A systematic literature review on obesity: understanding the causes & consequences of obesity and reviewing various machine learning approaches used to predict obesity. Comput Biol Med. 2021;136: 104754.","journal-title":"Comput Biol Med"},{"issue":"8608","key":"1474_CR2","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1016\/S0140-6736(88)90433-3","volume":"2","author":"M Sumeray","year":"1988","unstructured":"Sumeray M, Steiner M, Sutton P, Treasure T. Age and obesity as risk factors in perioperative atrial fibrillation. Lancet. 1988;2(8608):448.","journal-title":"Lancet"},{"issue":"21","key":"1474_CR3","doi-asserted-by":"publisher","first-page":"3247","DOI":"10.1161\/CIRCULATIONAHA.105.553743","volume":"112","author":"A Zacharias","year":"2005","unstructured":"Zacharias A, Schwann TA, Riordan CJ, Durham SJ, Shah AS, Habib RH. Obesity and risk of new-onset atrial fibrillation after cardiac surgery. Circulation. 2005;112(21):3247\u201355.","journal-title":"Circulation"},{"issue":"20","key":"1474_CR4","doi-asserted-by":"publisher","first-page":"2471","DOI":"10.1001\/jama.292.20.2471","volume":"292","author":"TJ Wang","year":"2004","unstructured":"Wang TJ, Parise H, Levy D, D\u2019Agostino RB Sr, Wolf PA, Vasan RS, et al. Obesity and the risk of new-onset atrial fibrillation. JAMA. 2004;292(20):2471\u20137.","journal-title":"JAMA"},{"issue":"3","key":"1474_CR5","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.jacep.2015.04.004","volume":"1","author":"CX Wong","year":"2015","unstructured":"Wong CX, Sullivan T, Sun MT, Mahajan R, Pathak RK, Middeldorp M, et al. Obesity and the risk of incident, post-operative, and post-ablation atrial fibrillation: a meta-analysis of 626,603 individuals in 51 studies. JACC Clin Electrophysiol. 2015;1(3):139\u201352.","journal-title":"JACC Clin Electrophysiol."},{"issue":"5","key":"1474_CR6","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","volume":"42","author":"G Hindricks","year":"2021","unstructured":"Hindricks G, Potpara T, Dagres N, Arbelo E, Bax JJ, Blomstrom-Lundqvist C, et al. 2020 ESC guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): the task force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart J. 2021;42(5):373\u2013498.","journal-title":"Eur Heart J"},{"issue":"12","key":"1474_CR7","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1161\/CIRCULATIONAHA.123.066279","volume":"149","author":"SM Patel","year":"2024","unstructured":"Patel SM, Braunwald E, Steffel J, Boriani G, Palazzolo MG, Antman EM, et al. Efficacy and safety of non-vitamin-k antagonist oral anticoagulants versus warfarin across the spectrum of body mass index and body weight: an individual patient data meta-analysis of 4 randomized clinical trials of patients with atrial fibrillation. Circulation. 2024;149(12):932\u201343.","journal-title":"Circulation"},{"issue":"36","key":"1474_CR8","doi-asserted-by":"publisher","first-page":"3314","DOI":"10.1093\/eurheartj\/ehae176","volume":"45","author":"IC Van Gelder","year":"2024","unstructured":"Van Gelder IC, Rienstra M, Bunting KV, Casado-Arroyo R, Caso V, Crijns H, et al. 2024 ESC guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2024;45(36):3314\u2013414.","journal-title":"Eur Heart J"},{"issue":"10","key":"1474_CR9","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.1093\/europace\/euab065","volume":"23","author":"J Steffel","year":"2021","unstructured":"Steffel J, Collins R, Antz M, Cornu P, Desteghe L, Haeusler KG, et al. 2021 European Heart Rhythm Association practical guide on the use of non-vitamin k antagonist oral anticoagulants in patients with atrial fibrillation. Europace. 2021;23(10):1612\u201376.","journal-title":"Europace"},{"issue":"6","key":"1474_CR10","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1111\/jth.13323","volume":"14","author":"K Martin","year":"2016","unstructured":"Martin K, Beyer-Westendorf J, Davidson BL, Huisman MV, Sandset PM, Moll S. Use of the direct oral anticoagulants in obese patients: guidance from the SSC of the ISTH. J Thromb Haemost. 2016;14(6):1308\u201313.","journal-title":"J Thromb Haemost"},{"issue":"6","key":"1474_CR11","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1007\/s11739-023-03334-4","volume":"18","author":"M Guarascio","year":"2023","unstructured":"Guarascio M, Bertu L, Donadini MP, Antonucci E, Palareti G, Ageno W. DOACs use in extreme body-weighted patients: results from the prospective START-register. Intern Emerg Med. 2023;18(6):1681\u20137.","journal-title":"Intern Emerg Med"},{"issue":"5","key":"1474_CR12","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.jacep.2021.02.002","volume":"7","author":"AF Barakat","year":"2021","unstructured":"Barakat AF, Jain S, Masri A, Alkukhun L, Senussi M, Sezer A, et al. Outcomes of direct oral anticoagulants in atrial fibrillation patients across different body mass index categories. JACC Clin Electrophysiol. 2021;7(5):649\u201358.","journal-title":"JACC Clin Electrophysiol."},{"issue":"1","key":"1474_CR13","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1111\/jth.13572","volume":"15","author":"A Tripodi","year":"2017","unstructured":"Tripodi A. To measure or not to measure direct oral anticoagulants before surgery or invasive procedures: reply. J Thromb Haemost. 2017;15(1):202\u20134.","journal-title":"J Thromb Haemost"},{"issue":"2","key":"1474_CR14","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1515\/cclm-2014-0767","volume":"53","author":"G Lippi","year":"2015","unstructured":"Lippi G, Favaloro EJ. Recent guidelines and recommendations for laboratory assessment of the direct oral anticoagulants (DOACs): is there consensus? Clin Chem Lab Med. 2015;53(2):185\u201397.","journal-title":"Clin Chem Lab Med"},{"issue":"3","key":"1474_CR15","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1161\/CIRCULATIONAHA.116.022307","volume":"134","author":"JI Weitz","year":"2016","unstructured":"Weitz JI, Eikelboom JW. Urgent need to measure effects of direct oral anticoagulants. Circulation. 2016;134(3):186\u20138.","journal-title":"Circulation"},{"issue":"3","key":"1474_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.cpcardiol.2019.02.002","volume":"46","author":"D Menichelli","year":"2021","unstructured":"Menichelli D, Ettorre E, Pani A, Violi F, Pignatelli P, Pastori D. Update and unmet needs on the use of nonvitamin k oral anticoagulants for stroke prevention in patients with atrial fibrillation. Curr Probl Cardiol. 2021;46(3): 100410.","journal-title":"Curr Probl Cardiol"},{"key":"1474_CR17","unstructured":"Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser. 2000;894:i\u2013xii (1\u2013253)."},{"issue":"9","key":"1474_CR18","doi-asserted-by":"publisher","first-page":"e255","DOI":"10.1016\/j.clinthera.2021.07.003","volume":"43","author":"V Russo","year":"2021","unstructured":"Russo V, Cattaneo D, Giannetti L, Bottino R, Laezza N, Atripaldi U, et al. Pharmacokinetics of direct oral anticoagulants in patients with atrial fibrillation and extreme obesity. Clin Ther. 2021;43(9):e255\u201363.","journal-title":"Clin Ther"},{"issue":"2","key":"1474_CR19","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1055\/s-0040-1715834","volume":"121","author":"AC Martin","year":"2021","unstructured":"Martin AC, Thomas W, Mahir Z, Crowley MP, Dowling T, Breen K, et al. Direct oral anticoagulant concentrations in obese and high body weight patients: a cohort study. Thromb Haemost. 2021;121(2):224\u201333.","journal-title":"Thromb Haemost"},{"issue":"4","key":"1474_CR20","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1002\/rth2.12146","volume":"2","author":"S Piran","year":"2018","unstructured":"Piran S, Traquair H, Chan N, Bhagirath V, Schulman S. Peak plasma concentration of direct oral anticoagulants in obese patients weighing over 120 kilograms: a retrospective study. Res Pract Thromb Haemost. 2018;2(4):684\u20138.","journal-title":"Res Pract Thromb Haemost."},{"issue":"11","key":"1474_CR21","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1177\/1060028020923584","volume":"54","author":"J Sebaaly","year":"2020","unstructured":"Sebaaly J, Kelley D. Direct oral anticoagulants in obesity: an updated literature review. Ann Pharmacother. 2020;54(11):1144\u201358.","journal-title":"Ann Pharmacother"},{"key":"1474_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.115281","volume":"166","author":"J Gouju","year":"2023","unstructured":"Gouju J, Legeay S. Pharmacokinetics of obese adults: not only an increase in weight. Biomed Pharmacother. 2023;166: 115281.","journal-title":"Biomed Pharmacother"},{"issue":"3","key":"1474_CR23","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1053\/j.gastro.2008.01.049","volume":"134","author":"MF Vaezi","year":"2008","unstructured":"Vaezi MF. GERD and obesity: a real BIG issue! Gastroenterology. 2008;134(3):882\u20133.","journal-title":"Gastroenterology"},{"issue":"8","key":"1474_CR24","doi-asserted-by":"publisher","first-page":"1846","DOI":"10.1182\/bloodadvances.2023012408","volume":"8","author":"S Testa","year":"2024","unstructured":"Testa S, Palareti G, Legnani C, Dellanoce C, Cini M, Paoletti O, et al. Thrombotic events associated with low baseline direct oral anticoagulant levels in atrial fibrillation: the MAS study. Blood Adv. 2024;8(8):1846\u201356.","journal-title":"Blood Adv"},{"key":"1474_CR25","doi-asserted-by":"crossref","unstructured":"Harenberg J, Gosselin RC, Cuker A, Becattini C, Pabinger I, Poli S, et al. Algorithm for rapid exclusion of clinically relevant plasma levels of direct oral anticoagulants in patients using the DOAC dipstick: an expert consensus paper. J Thromb Haemost. 2024.","DOI":"10.1055\/s-0044-1779224"},{"key":"1474_CR26","doi-asserted-by":"crossref","unstructured":"Dionne CW, Braeken RB, Yvonne MC, Henskens HC, Rutger CC, Hengeveld BA, Hutten SM, Coppens M, Stroobants AK. Clinical characteristics of patients with direct oral anticoagulant (DOAC) levels outside expected ranges: a retrospective chart study. Thrombosis Update. 2023;11.","DOI":"10.1016\/j.tru.2023.100139"}],"container-title":["Clinical Pharmacokinetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40262-025-01474-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40262-025-01474-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40262-025-01474-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T01:02:32Z","timestamp":1773795752000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40262-025-01474-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,12]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["1474"],"URL":"https:\/\/doi.org\/10.1007\/s40262-025-01474-8","relation":{},"ISSN":["0312-5963","1179-1926"],"issn-type":[{"value":"0312-5963","type":"print"},{"value":"1179-1926","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,12]]},"assertion":[{"value":"31 December 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2026","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original online version of this article was revised to include the Supplementary Material.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Open access funding provided by Universit\u00e0 degli Studi di Roma La Sapienza within the CRUI-CARE Agreement.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"The authors declare that they have no potential conflicts of interest that might be relevant to the contents of this manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"D.M. and A.P. carried out conceptualization, analysis, writing original draft, and methodology; E.B., V. Cammisotto, V. Castellani, R.M., and I.M.P. carried out data curation, methodology, and investigation; A.C., F.V., J.H., D.P., and P.P. carried out supervision, validation, and reviewing of original draft and editing.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author contributions"}},{"value":"The datasets generated during and\/or analyzed during the current study are available from the corresponding author on reasonable request.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data availability statement"}},{"value":"The study was approved by the local ethics committee of Sapienza University (no. 0234\/2022) and was conducted according to the 1975 Declaration of Helsinki.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}},{"value":"All patients signed informed written consent at study entry.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}